Rapid induction of colonic adenocarcinoma in mice exposed to benzo[a]pyrene and dextran sulfate sodium

Food and Chemical Toxicology

Volumn 49, Issue 11, 2011, Pages 2997-3001

  Hakura, Atsushi ^a   Seki, Yuki ^a   Sonoda, Jiro ^a   Hosokawa, Satoru ^a   Aoki, Toyohiko ^a   Suganuma, Akiyoshi ^a   Kerns, William D ^b   Tsukidate, Kazuo ^a  

^a EISAI CO LTD   (Japan)

^b Accellient Partners LLC   (United States)

Author keywords

Benzo a pyrene; Colon; Dextran sulfate sodium; Inflammation; Mouse; Tumor

Indexed keywords

BENZO[A]PYRENE; DEXTRAN SULFATE; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; EXPOSURE; GENETIC ASSOCIATION; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; MUTAGENESIS; MUTATION RATE; NONHUMAN;

ADENOCARCINOMA; ADENOMA; ANIMALS; BENZO(A)PYRENE; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; DRUG INTERACTIONS; INFLAMMATION; MALE; MICE; MUTATION;

MUS;

EID: 84860390452     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.07.057     Document Type: Article

References (27)

1. Bolt A.B., Papanikolaou A., Delker D.A., Wang Q.-S., Rosenberg D.W. Azoxymethane induces Ki-ras activation in the tumor resistant AKR/J mouse colon. Mol. Carcinog. 2000, 27:210-218.
2. Clapper M.L., Cooper H.S., Chang W.-C.L. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol. Sin. 2007, 28:1450-1459.
3. Culp S.J., Gaylor D.W., Sheldon W.G., Goldstein L.S., Beland F.A.A. Comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis 1998, 19:117-124.
4. Gold L.S., Slone T.H., Manley N.B., Bernstein L. Target organs in chronic bioassays of 533 chemical carcinogens. Environ. Health Perspect. 1991, 93:233-246.
5. Hachiya N., Yajima N., Hatakeyama S., Yuno K., Okada N., Umeda Y., Wakata A., Motohashi Y. Induction of lacZ mutation by 7, 12-dimethylbenz[a]anthracene in various tissues of transgenic mice. Mutat. Res. 1999, 444:283-295.
6. Hakura A., Tsutsui Y., Sonoda J., Kai J., Imade T., Shimada M., Sugihara Y., Mikami T. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse). Mutat. Res. 1998, 398:123-130.
7. Hakura A., Sonoda J., Tsutsui Y., Mikami T., Imade T., Shimada M., Yaguchi S., Yamanaka M., Tomimatsu M., Tsukidate K. Toxicity profile of benzo[a]pyrene in the malelacZ transgenic mouse (MutaMouse) following oral administration for 5 consecutive days. Regul. Toxicol. Pharmacol. 1998, 27:273-279.
8. Hakura A., Tsutsui Y., Sonoda J., Mikami T., Tsukidate K., Sagami F., Kerns W.D. Multiple organ mutation in the lacZ transgenic mouse (Muta™Mouse) 6months after oral treatment (5days) with benzo[a]pyrene. Mutat. Res. 1999, 426:71-77.
9. Min mice exposed to benzo[a]pyrene. Toxicol. Pathol. 2009, 37:938-946.
10. Humphries A., Wright N.A. Colonic crypt organization and tumorigenesis. Nat. Rev. 2008, 8:415-424.
11. International Agency for Research on Cancer, 2010. Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. IARC, Lyon, vol. 92, pp. 394-423, http://www.monographs.iarc.fr/.
12. Itoh T., Kuwahara T., Suzuki T., Hayashi M., Ohnishi Y. Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene of lambda/lacZ transgenic mine. Mutat. Res. 2003, 539:99-108.
13. Kuraguchi M., Thomas G.A., Williams E.D. Somatic mutation of the glucose-6-phosphate dehydrogenase (g6pd) gene in colonic stem cells and crypt restricted loss of G6PD activity. Mutat. Res. 1997, 379:69-75.
14. Lambert I.B., Singer T.M., Boucher S.E., Douglas G.R. Detailed review of transgenic rodent mutation assays. Mutat. Res. 2005, 590:1-280.
15. Marchand L.L., Hankin J.H., Pierce L.M., Sinha R., Nerurkar P.V., Franke A.A., Wilkerns L.R., Kolonel L.N., Donlon T., Seifried A., Custer L.J., Lum-Jones A., Chang W. Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat. Res. 2002, 506-507:205-214.
16. Nagao M., Fujita H., Ochiai M., Wakabayashi K., Sofuni T., Matsushima T., Sugimura T., Ushijima T. No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue® mice. Mutat. Res. 1998, 400:251-257.
17. Newell L.E., Heddle J.A. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon. Mutat. Res. 2004, 564:1-7.
18. Nohmi T., Suzuki T., Masumura K. Recent advances in the protocols of transgenic mouse mutation assays. Mutat. Res. 2000, 455:191-215.
19. Pascal R.R. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal carcinomas. Hum. Pathol. 1994, 25:1160-1171.
20. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 1999, 443:139-147.
21. Riddell R.H., Goldman H., Ransohof D.F., Appleman H.D., Fenoglio C.M., Haggitt R.C., Ahren C., Correa P., Hamilton S.R., Morson B.C., Sommers S.C., Yardley J.H. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Hum. Pathol. 1983, 14:931-968.
22. Rosenberg D., Giardina C., Tanaka T. Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009, 30:183-196.
23. Schoket B. DNA damage in humans exposed to environmental and dietary polycyclic aromatic hydrocarbons. Mutat. Res. 1999, 424:143-153.
24. Sinha R., Peters U., Cross A.J., Kulldorff M., Weissfeld J.L., Pinsky P.F., Rothman N., Hayes R.B. Prostate, lung, colorectal, and ovarian cancer project team. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res. 2005, 65:8034-8041.
25. Tanaka T. Colorectal carcinogenesis: review of human and experimental animal studies. J. Carcinog. 2009, 8:1-19.
26. Ward J.M. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest. 1974, 30:505-513.
27. Westbrook A.M., Szakmary A., Schiestl R.H. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat. Res. 2010, 705:40-59.